FDA NDC Directory · JSON-LD · Markdown

MESALAMINE

NDC 0527-3012 · HUMAN PRESCRIPTION DRUG · TABLET, DELAYED RELEASE

Generic namemesalamine
Labeler / ManufacturerLannett Company Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA217337
Dosage form / routeTABLET, DELAYED RELEASE · ORAL
Active ingredientsMESALAMINE (1.2 g/1)
Marketing started20230603
Package count1

External sources

Source: openFDA. Public-domain (CC0).